证券代码：002001 证券简称：新 和 成 公告编号：2015-033 浙江新和成股份有限公司 2015 年第三季度报告正文 2015 年 10 月 浙江新和成股份有限公司 2015 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人胡柏藩、主管会计工作负责人石观群及会计机构负责人(会计主管人员)杨徐 燕声明：保证季度报告中财务报表的真实、准确、完整。 1 浙江新和成股份有限公司 2015 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 9,053,458,876.86 | 9,123,764,118.06 | | -0.77% | | 归属于 ...

Financial Performance - The company reported a revenue of CNY 1.93 billion for the first half of 2015, a decrease of 9.35% compared to the same period last year[20]. - The net profit attributable to shareholders was CNY 185.62 million, down 66.17% year-on-year[20]. - The net profit after deducting non-recurring gains and losses was CNY 151.69 million, a decline of 72.11% compared to the previous year[20]. - The net cash flow from operating activities was CNY 320.11 million, a decrease of 35.22% from the same period last year[20]. - Basic earnings per share were CNY 0.17, down 66.16% year-on-year[20]. - Total assets at the end of the reporting period were CNY 8.94 billion, a decrease of 2.04% from the end of the previous year[20]. - The net assets attributable to shareholders were CNY 6.82 billion, down 2.78% compared to the previous year[20]. - The total profit for the period was CNY 23,082,380, representing a significant decline of 65.42% year-on-year[32]. - The gross profit margin for the pharmaceutical and chemical sector was 27.42%, down 16.65 percentage points year-on-year[35]. - The company reported a significant increase in financial expenses by 590.70% due to exchange rate fluctuations[32]. Market Conditions and Strategy - The overall market conditions remain challenging, with product prices hitting historical lows due to weak demand in the aquaculture industry[30]. - The company plans to focus on product innovation, marketing innovation, and management innovation to drive growth[30]. - The company plans to expand its market presence by increasing exports, targeting a growth rate of 10% in international sales for the next fiscal year[49]. - New product development includes the introduction of industrial fragrance materials, with projected sales of 626.86 million CNY for the upcoming year[50]. - The company has initiated a strategic partnership with a leading chemical manufacturer to enhance production efficiency, expected to reduce costs by 5%[49]. - A new acquisition strategy is in place, focusing on acquiring smaller firms in the specialty chemicals sector to boost market share by 20% over the next two years[50]. Cash Flow and Investments - The company did not engage in any external investments or hold any financial enterprise equity during the reporting period[37][38]. - The company reported a cash balance of approximately ¥2.43 billion at the end of the period, down from ¥2.75 billion at the beginning of the period, indicating a decrease of about 11.5%[197]. - The company has a total of ¥97.83 million in other monetary funds at the end of the period, which is an increase from ¥42.58 million at the beginning of the period, representing a growth of approximately 129.5%[197]. - The company has recognized trading financial assets valued at ¥4.66 million at the end of the period, with no initial balance reported[199]. - The investment activities generated a net cash flow of -¥350,486,510.46, slightly improved from -¥351,504,314.59 in the previous period[125]. Shareholder and Dividend Information - The company will not distribute cash dividends or issue bonus shares for this reporting period[5]. - The company distributed a cash dividend of 3.5 RMB per 10 shares, totaling 381,121,650.00 RMB, approved at the 2014 annual general meeting[55]. - The total amount of related party transactions during the reporting period was 4,642.6 million RMB, with a total approved transaction amount of 11,500 million RMB[68]. - The company has not made any adjustments to its cash dividend policy during the reporting period[56]. Compliance and Governance - The company has maintained compliance with corporate governance regulations and has not faced any media scrutiny during the reporting period[61][62]. - There were no significant litigation or arbitration matters during the reporting period[62]. - The company has not conducted any asset acquisitions or sales during the reporting period[64][66]. - The semi-annual financial report was not audited[104]. Financial Position and Assets - The company's total assets decreased to CNY 5,850,096,757.07 from CNY 6,141,357,738.50, a reduction of about 4.74%[112]. - The company's current assets totaled CNY 2,745,737,944.03, down from CNY 3,122,903,151.50, indicating a decline of approximately 12.06%[111]. - The total liabilities decreased to CNY 1,135,273,071.51 from CNY 1,280,106,351.52, reflecting a decrease of approximately 11.32%[113]. - The company's equity attributable to shareholders was CNY 6,819,903,319.28, down from CNY 7,015,166,458.12, a decrease of approximately 2.79%[109]. Accounting Policies and Financial Reporting - The company adheres to specific accounting policies for receivables, fixed assets, and revenue recognition, ensuring accurate financial reporting[146]. - The company’s financial reporting period aligns with the calendar year, from January 1 to December 31[148]. - The company has no significant changes in accounting policies or estimates during the reporting period[193]. - The corporate income tax rate applicable to the company and its subsidiaries is 15%, while other entities are subject to a 25% tax rate[194]. - The company is classified as a high-tech enterprise, allowing it to benefit from a reduced corporate income tax rate of 15%[194].

Financial Performance - The company's operating revenue for Q1 2015 was ¥957,675,625.58, a decrease of 0.67% compared to ¥964,098,719.23 in the same period last year[6] - Net profit attributable to shareholders was ¥80,427,695.62, down 60.48% from ¥203,536,075.96 year-on-year[6] - The net profit after deducting non-recurring gains and losses was ¥66,250,845.79, a decline of 67.55% compared to ¥204,177,692.46 in the previous year[6] - The net cash flow from operating activities was ¥110,078,428.35, representing a decrease of 54.62% from ¥242,571,640.97 in the same period last year[6] - Basic and diluted earnings per share were both ¥0.07, down 63.16% from ¥0.19 in the previous year[6] - The weighted average return on equity decreased by 1.91 percentage points to 1.14% from 3.05% year-on-year[6] Assets and Shareholder Information - Total assets at the end of the reporting period were ¥9,179,666,732.72, an increase of 0.61% from ¥9,123,764,118.06 at the end of the previous year[6] - Net assets attributable to shareholders increased by 1.16% to ¥7,096,286,219.12 from ¥7,015,166,458.12 at the end of the previous year[6] - The total number of ordinary shareholders at the end of the reporting period was 56,547[10] - The largest shareholder, Xinhacheng Holding Group, held 56.36% of the shares, totaling 613,678,257 shares[10] Changes in Financial Assets and Liabilities - Financial assets measured at fair value increased by 100% compared to the beginning of the year, due to changes in the fair value of forward foreign exchange contracts[14] - Prepaid accounts increased by 154.67% compared to the beginning of the year, attributed to an increase in prepaid raw material payments[14] - Other current assets increased by 138.41% compared to the beginning of the year, due to an increase in the purchase of financial products[14] - The company reported a significant increase of 7,605.74% in long-term borrowings compared to the beginning of the year, due to new foreign currency borrowings[14] Income and Expenses - Investment income increased by 319.50% year-on-year, due to higher profits from joint ventures and increased returns from financial products[14] - The company experienced a 34.27% increase in business taxes and additional charges compared to the same period last year, due to an increase in VAT payable[14] - The company’s financial expenses increased by 3,267.21% year-on-year, primarily due to significant foreign exchange losses[14] - The company’s employee compensation payable decreased by 52.80% compared to the beginning of the year, mainly due to the payment of last year's accrued year-end bonuses[14] - The company’s asset impairment losses decreased by 112.94% year-on-year, attributed to a reduction in inventory write-downs[14] Future Projections - The net profit attributable to shareholders for the first half of 2015 is expected to decrease by 80.00% to 60.00% compared to the same period in 2014, with a range of 10,974.47 to 21,948.95 million yuan[16]

Financial Performance - The company's operating revenue for 2014 was ¥4,164,209,211.21, a decrease of 1.73% compared to ¥4,237,635,148.40 in 2013[21] - The net profit attributable to shareholders for 2014 was ¥808,040,363.80, down 8.40% from ¥882,120,714.89 in the previous year[21] - Basic earnings per share for 2014 were ¥0.74, a decline of 8.64% compared to ¥0.81 in 2013[21] - The total profit for 2014 was CNY 1,016.49 million, down 4.03% year-on-year, while net profit attributable to shareholders was CNY 808.04 million, a decline of 8.40%[30] - The company reported a total revenue of 503.22 million RMB, with a net profit of -21.85 million RMB, indicating a significant decline compared to previous periods[62] - The net profit for the year was 633,545,597.23 CNY, down from 1,018,383,639.30 CNY in the previous year, indicating a decline of about 37.8%[188] - The total comprehensive income for the year was 633,548,455.17 CNY, down from 1,018,841,997.56 CNY in the previous year, a decline of approximately 37.8%[189] Cash Flow and Investments - The net cash flow from operating activities decreased by 19.12% to ¥1,079,736,503.00 from ¥1,335,018,638.43 in 2013[21] - The company’s cash and cash equivalents decreased by CNY 32.52 million, marking a decline of 108.35% from the previous year[39] - Investment cash inflow decreased by 63.79% year-on-year due to a significant reduction in cash recovered from the disposal of fixed assets, intangible assets, and other long-term assets[40] - Net cash flow from investment activities fell by 48.87% year-on-year, attributed to a decline in cash recovered from asset disposals and an increase in cash payments related to investment activities[40] - The cash flow from operating activities was 1,079,736,503.00 CNY, compared to 1,335,018,638.43 CNY in the previous year, a decrease of about 19.2%[192] - The company incurred a net cash outflow from investing activities of 810,935,254.06 CNY, worsening from a net outflow of 544,743,035.19 CNY in the previous year[192] Assets and Liabilities - The total assets at the end of 2014 increased by 6.64% to ¥9,123,764,118.06 from ¥8,555,874,591.90 at the end of 2013[21] - The company's total liabilities amounted to RMB 2,108,597,659.94, up from RMB 1,985,316,889.73, indicating an increase of about 6.2%[177] - The company's total equity reached RMB 7,015,166,458.12, compared to RMB 6,570,557,702.17 at the start of the year, representing a growth of approximately 6.8%[178] - The company's inventory increased to RMB 1,242,098,435.97 from RMB 1,142,192,652.91, marking a growth of approximately 8.8%[175] Research and Development - The company invested over CNY 200 million in research and development during the reporting period, resulting in 13 authorized invention patents, including one in Germany and the USA[31] - The company’s R&D expenditure as a percentage of audited net assets increased to 3.19% from 2.90% in the previous year[38] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of ¥3.50 per 10 shares, totaling approximately ¥38,116,165.50 based on the total share capital of 1,088,919,000 shares[4] - The cash dividend payout ratio increased from 41.15% in 2013 to 47.17% in 2014, reflecting a positive trend in profit allocation to shareholders[76] - In 2014, the company proposed a cash dividend of RMB 3.5 per 10 shares, totaling RMB 381,121,650, which represents 100% of the profit distribution[77] Market and Competition - The company faces risks related to industry competition and exchange rate fluctuations, which may impact future performance[12] - The company maintained a strong competitive position in the fine chemical industry, particularly in nutrition products and flavoring agents, with no significant changes in core competitiveness during the reporting period[48] - Over 60% of the company's sales revenue comes from international markets, primarily the US and Europe, making it vulnerable to exchange rate fluctuations[68] Corporate Governance and Management - The company has established a governance structure that complies with the Company Law and Securities Law, ensuring independent operations of the board and supervisory committee[143] - The management team has extensive experience in the industry, with many members serving in their roles for over a decade[130] - The company has actively improved its investor relations management to enhance governance levels[143] Employee and Director Compensation - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to 9.41 million yuan, with an additional 160,000 yuan from shareholder units[137] - The performance evaluation and incentive mechanism is transparent, linking the compensation of directors and senior management to company performance and individual achievements[144] Strategic Initiatives - The company is focused on expanding its market presence through strategic partnerships and acquisitions[132] - The company has a clear strategy for future development and project investments, as discussed by the strategic committee[152]

一、本期业绩预计情况： 1、业绩预告期间：2015 年 1 月 1 日—2015 年 3 月 31 日 证券代码：002001 证券简称：新和成 公告编号：2015-003 浙江新和成股份有限公司 2015 年第一季度业绩预告 本公司及其董事、监事、高级管理人员保证公告内容真实、准确和完整，并 对公告中的虚假记载、误导性陈述或者重大遗漏承担责任。 本次业绩预告未经注册会计师预审计。 由于公司主导产品维生素 E 销售价格同比下降，导致公司 2015 年一季度净 利润同比下降。 三、业绩变动原因说明 四、其他相关说明 2、预计的业绩：□亏损 扭亏为盈 □同向上升 √ 同向下降 | 项目 | 本报告期（2015年1-3月） | 上年同期 | | --- | --- | --- | | 归属于上市公司股 | 比上年同期：-70% — -50% | 盈利:20,353.61万元 | | 东的净利润 | 盈利：6,106.08万元—10,176.81万元 | | 二、业绩预告预审计情况 本次业绩预告是公司财务部门初步测算结果，具体财务数据以公司披露的 2015年第一季度报告为准。敬请广大投资者注意。 特此公告。 浙江新和 ...

Financial Performance - Total revenue for 2014 was CNY 4,163.84 million, a decrease of 1.74% compared to CNY 4,237.63 million in 2013[4] - Operating profit for 2014 was CNY 1,003.59 million, down 3.38% from CNY 1,038.69 million in 2013[4] - Net profit attributable to shareholders for 2014 was CNY 808.26 million, representing an 8.37% decline from CNY 882.12 million in 2013[4] - Basic earnings per share for 2014 decreased to CNY 0.74, down 8.64% from CNY 0.81 in 2013[4] - The weighted average return on equity decreased by 2.08 percentage points in 2014[4] - There were no discrepancies between the reported operating performance and the previous earnings forecast[7] Assets and Equity - Total assets increased by 6.65% to CNY 9,124.76 million in 2014, compared to CNY 8,555.87 million in 2013[4] - Shareholder equity attributable to the company increased by 6.77% to CNY 7,015.39 million in 2014, up from CNY 6,570.56 million in 2013[4] - The number of shares increased by 50% to 1,088.91 million shares in 2014 from 725.95 million shares in 2013[4] Product Performance - The company’s main product, Vitamin E, saw a decrease in sales price, while sales volume for Vitamin E and Vitamin A increased[6]

Financial Forecast Revision - The company revised its 2014 net profit forecast to between 793.91 million and 882.12 million CNY, representing a decrease of 10% to 0% compared to the previous year[3] - The previous forecast estimated a net profit of 882.12 million to 1.14676 billion CNY for 2014[3] - The performance forecast revision has not been audited by registered accountants[4] Reasons for Decline - The decline in net profit is attributed to a decrease in the sales price of the company's main product, Vitamin E[5] Investor Communication - The company expressed sincere apologies for any inconvenience caused to investors due to the performance forecast revision[6]

浙江新和成股份有限公司 2014 年第三季度报告正文 证券代码：002001 证券简称：新 和 成 公告编号：2014-025 浙江新和成股份有限公司 2014 年第三季度报告正文 1 浙江新和成股份有限公司 2014 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚 假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人胡柏藩、主管会计工作负责人石观群及会计机构负责人(会计主管人员)杨徐燕声明：保证 季度报告中财务报表的真实、准确、完整。 2 浙江新和成股份有限公司 2014 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 8,942,780,305.71 | 8,555,874,591.90 | ...

Financial Performance - The company's operating revenue for the first half of 2014 was CNY 2,130,497,928.40, representing a 5.55% increase compared to CNY 2,018,440,079.96 in the same period last year[21]. - Net profit attributable to shareholders was CNY 548,723,718.22, a 33.46% increase from CNY 411,141,329.40 year-on-year[21]. - The net profit after deducting non-recurring gains and losses was CNY 543,999,717.00, up 29.51% from CNY 420,044,435.85 in the previous year[21]. - The net cash flow from operating activities was CNY 494,142,950.89, reflecting a 15.44% increase compared to CNY 428,666,411.07 in the same period last year[21]. - Basic earnings per share increased to CNY 0.50, a rise of 31.58% from CNY 0.38[21]. - Total assets at the end of the reporting period were CNY 8,924,304,040.75, up 4.31% from CNY 8,555,874,591.90 at the end of the previous year[21]. - Net assets attributable to shareholders increased to CNY 6,756,851,069.45, a 2.84% rise from CNY 6,570,557,702.17 at the end of the previous year[21]. - The weighted average return on equity rose to 8.16%, an increase of 1.46 percentage points compared to 6.70% in the previous year[21]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[7]. - The company completed the registration of its increased capital stock, raising the total share capital from 725,946,000 shares to 1,088,919,000 shares[19]. - The company’s shareholder structure remains unaffected despite the increase in share capital[70]. - New Hope Holdings Group holds 56.36% of shares, totaling 613,678,257 shares, with an increase of 204,559,419 shares during the reporting period[72]. - The total number of common shareholders at the end of the reporting period is 38,288[72]. - The company did not experience any changes in its controlling shareholder or actual controller during the reporting period[74]. - The company has not reported any pledged or frozen shares among its major shareholders[72]. - The report indicates that there are no related party transactions among the top shareholders[73]. Investment and R&D - Research and development investment increased by 31.48% to 91.44 million yuan, reflecting a stronger focus on R&D[34]. - The company is actively engaged in research and development of new products, particularly in the field of food and feed additives[175]. - Future expansion plans include increasing production capacity and enhancing export services to meet growing international demand[176]. - The company is exploring new markets for its products, particularly in the Asia-Pacific region, to drive growth[176]. Financial Structure and Compliance - The governance structure of the company was improved in accordance with relevant laws and regulations, ensuring compliance and enhancing investor relations[54]. - The company adheres to the accounting standards for enterprises, ensuring compliance in its financial reporting[111]. - The financial statements are prepared based on the principle of going concern, ensuring a true and complete reflection of the company's financial status and operating results[111]. - The company has not changed its main accounting policies or estimates during the reporting period[171]. Cash Flow and Liquidity - Cash and cash equivalents at the end of the period amounted to ¥2,712,039,083.13, up from ¥2,664,710,568.85, indicating a growth of 1.8%[85]. - The company reported a net cash flow from operating activities of ¥494,142,950.89, an increase of 15.3% from ¥428,666,411.07 in the previous period[97]. - The cash flow from operating activities decreased by 11.9% from the previous period, indicating a need for strategic adjustments[98]. - The total cash and cash equivalents at the end of the period increased to ¥1,668,486,097.81, up from ¥686,724,405.65 at the end of the previous period[99]. Market Position and Competitiveness - The company’s core competitiveness remains strong, with leading market share in its main products[38]. - The company is committed to maintaining high standards in product quality and compliance with international regulations[175]. - The management provided optimistic guidance for the second half of 2014, expecting continued revenue growth and market expansion[176]. Related Party Transactions - The company engaged in significant related party transactions amounting to 5,092.47 million yuan, representing 2.51% and 1.75% of operating income from two major suppliers[62]. - The company’s related party transactions were conducted at market prices, ensuring compliance with pricing principles[62]. Asset Management - The company did not engage in any asset acquisitions or sales during the reporting period[58][59]. - The company has a total of approximately 1,590.62 million restricted shares and 1,073.0128 million unrestricted shares[109]. - The company has confirmed that impairment provisions for investments in subsidiaries, joint ventures, and associates are recognized when the carrying amount exceeds the recoverable amount[141].

Financial Performance - Operating revenue for Q1 2014 was ¥964,098,719.23, a decrease of 5.53% compared to ¥1,020,516,894.48 in the same period last year[7] - Net profit attributable to shareholders was ¥203,536,075.96, an increase of 7.34% from ¥189,617,276.49 year-on-year[7] - Basic earnings per share rose to ¥0.28, reflecting a 7.69% increase from ¥0.26 in the previous year[7] - The net profit attributable to shareholders for the first half of 2014 is expected to increase by 30% to 60%[17] - The projected net profit range for the first half of 2014 is between 534.48 million and 657.83 million yuan[17] - The net profit for the first half of 2013 was 411.14 million yuan[17] Cash Flow and Assets - Net cash flow from operating activities decreased by 24.4% to ¥242,571,640.97, down from ¥320,860,339.35 in the same period last year[7] - Total assets at the end of the reporting period were ¥8,690,024,171.22, an increase of 1.57% from ¥8,555,874,591.90 at the end of the previous year[7] - Net assets attributable to shareholders increased by 3.11% to ¥6,774,584,754.81 from ¥6,570,557,702.17 at the end of the previous year[7] Changes in Current Assets - The company reported a significant increase in other current assets by 228.68%, primarily due to the purchase of financial products during the reporting period[16] - Prepayments increased by 165.89%, mainly due to increased advance payments for housing by a subsidiary[16] Expenses and Investment - Sales expenses rose by 65.92% due to increased transportation costs associated with higher product sales volume[16] - Investment income increased by 47.7%, attributed to higher profits from associated enterprises compared to the previous year[16] Market Conditions - The increase in performance is attributed to changes in the market conditions for the company's main products, VE and VA, leading to an adjustment in their external pricing[17]